期刊文献+

腹膜透析开始时残余肾功能对预后影响的研究 被引量:5

Effect of residual renal function on patient prognosis at the initiation of peritoneal dialysis
原文传递
导出
摘要 目的探讨慢性肾脏病(CKD)5期患者在开始腹膜透析时残余肾功能对预后的影响。方法回顾性分析大连医科大学附属第一医院肾内科2006-12-01—2009-04-30行规律性腹膜透析患者118例。按肾小球滤过率(eGFR)(≤5mL/min,>5mL/min)及预后(死亡或存活)分别分为两组。比较开始透析时肾小球滤过率(eGFR)、血红蛋白、血清白蛋白、存活时间(月)、死亡情况。结果 eGFR≤5mL/min组62例,平均存活时间(15.86±1.34)个月,eGFR>5mL/min组56例,平均存活时间(24.05±1.18)个月,差异有统计学意义。eGFR≤5mL/min组患者白蛋白和血红蛋白明显低于eGFR>5mL/min组。Lo-gistic分析显示eGFR≤5mL/min,白蛋白低于30g/L,血红蛋白低于100g/L,年龄大于70岁是死亡的危险因素。结论开始透析时有较高残余肾功能的患者有较长的存活期,残余肾功能、白蛋白、血红蛋白和年龄是死亡的危险因素。 Objective To determine the effects of residual renal function on the mortality of patients at the beginning of peritoneal dialysis. Methods We retrospectively studied the clinical outcomes in patients ( n = 118) who underwent peritoneal dialysis at our hospital between Dec 1 2006 and Apr 30 2009. All patients were followed up for more than 3 months, eGFR, serum albumin, urea, creatinine, calcium, phosphorus and hemoglobin at the beginning of peritoneal dialysis and the survival time were recorded. They were grouped according to eGFR(≤5 mL/ min, 〉 5 mL/min) and survival or death. Results Mean survival period of 62 patients in eGFR ≤5 mlJmin group was shorter than that of 56 patients in eGFR 〉5 mL/min group[ (.15.86 ± 1.34) months vs (24. 05 ± 1.18) months ,P 〈 0. 05 ]. Death group had lower eGFR, serum ALB, calcium, and higher serum phosphorus than survival group. Conclusion The survival period is longer for the patients who have higher eGFR at the initiation of peritoneal dialysis.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2010年第6期544-545,共2页 Chinese Journal of Practical Internal Medicine
关键词 腹膜透析 残余肾功能 肾小球滤过率 peritoneal dialysis residual renal function eGFR
  • 相关文献

参考文献6

  • 1National Kidney Foundation. K/DOQI clinical practice guidelines for peritoneal dialysis adequacy [ J ]. Am J Kidney Dis, 1997,30 ( Suppl 2 ) : S70 - S73.
  • 2Angela Yee-Moon Wang, Mei Wang, Jean Woo, et al. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients [ J ]. J Am Soc Nephrol,2004,15:2186 -2194.
  • 3Xiao Yang, Wei Fang, Jaitan Kothari, et al. Clinical outcomes of elderly patients undergoing chronic peritoneal dialysis:experiences from one center and a review of the literature [J]. Int Urol Nephrol,2007,39 : 1295 - 1303.
  • 4Seoung Gu Kim, Nam Ho Kim. The effect of residual renal function at the initiation of dialysis on patient survival[J]. Korean J.Intem Med ,2009,24:55 - 62.
  • 5Phelan PJ, O'Kelly P, Walshe JJ. The importance of serum albumin and phosphorous as predictors of mortality in ESRD patients [ J ]. Ren Fail,2008,30 (4) :423 - 429.
  • 6Johnson DW. What is the optimal fat mass in peritoneal dialysis patients[ J]. Perit Dial Int ,2007,27 ( Suppl 2 ) : S250 - S254.

同被引文献36

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部